Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Parkinson's Disease

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 40 articles: HTML format Text format

Single Articles

January 2012
1. WILLIS AW , Schootman M, Kung N, Evanoff BA, et al
   Predictors of Survival in Patients With Parkinson Disease.
   Arch Neurol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GAN-OR Z , Bar-Shira A, Dahary D, Mirelman A, et al
   Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a Reduced Parkinson Disease Risk.
   Arch Neurol. 2012;69:105-10.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. DELUCA GC , Li G, Ramagopalan S
   Parkinson disease and vitamin d: an interplay between genes and the environment?
   Arch Neurol. 2011;68:1615-6.
   PubMed     Text format     Related articles   
   
   
   
   
4. WEINTRAUB D , Doshi J, Koka D, Davatzikos C, et al
   Neurodegeneration across stages of cognitive decline in Parkinson disease.
   Arch Neurol. 2011;68:1562-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
5. CASTRIOTO A , Lozano AM, Poon YY, Lang AE, et al
   Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation.
   Arch Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KIPFER S , Stephan MA, Schupbach WM, Ballinari P, et al
   Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia.
   Arch Neurol. 2011;68:1037-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SAVICA R , Matsumoto JY, Josephs KA, Ahlskog JE, et al
   Deep brain stimulation in benign tremulous parkinsonism.
   Arch Neurol. 2011;68:1033-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KATZ M , Kilbane C, Rosengard J, Alterman RL, et al
   Referring patients for deep brain stimulation: an improving practice.
   Arch Neurol. 2011;68:1027-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
9. BERG D , Seppi K, Behnke S, Liepelt I, et al
   Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
   Arch Neurol. 2011;68:932-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. GODAU J , Knauel K, Weber K, Brockmann K, et al
    Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease.
    Arch Neurol. 2011;68:925-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WEINTRAUB D , Chen P, Ignacio RV, Mamikonyan E, et al
    Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.
    Arch Neurol. 2011;68:899-904.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
12. KLEIN C , Krainc D, Schlossmacher MG, Lang AE, et al
    Translational research in neurology and neuroscience 2011: movement disorders.
    Arch Neurol. 2011;68:709-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
13. ROBOTTOM BJ , Weiner WJ, Factor SA
    Movement disorders emergencies. Part 1: Hypokinetic disorders.
    Arch Neurol. 2011;68:567-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
14. SETO-SALVIA N , Clarimon J, Pagonabarraga J, Pascual-Sedano B, et al
    Dementia Risk in Parkinson Disease: Disentangling the Role of MAPT Haplotypes.
    Arch Neurol. 2011;68:359-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. EVATT ML , Delong MR, Kumari M, Auinger P, et al
    High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease.
    Arch Neurol. 2011;68:314-319.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
16. MORENO-LOPEZ C , Santamaria J, Salamero M, Del Sorbo F, et al
    Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).
    Arch Neurol. 2011;68:223-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
17. CHEN H , Gao X, Ascherio A
    Prospective research on Parkinson nonmotor symptoms.
    Arch Neurol. 2011;68:137.
    PubMed     Text format     Related articles   
    
    
    
    
18. WU Y , Le W, Jankovic J
    Preclinical biomarkers of Parkinson disease.
    Arch Neurol. 2011;68:22-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
19. HEMMING JP , Gruber-Baldini AL, Anderson KE, Fishman PS, et al
    Racial and Socioeconomic Disparities in Parkinsonism.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
20. BRUGGEMANN N , Hagenah J, Reetz K, Schmidt A, et al
    Recessively Inherited Parkinsonism: Effect of ATP13A2 Mutations on the Clinical and Neuroimaging Phenotype.
    Arch Neurol. 2010;67:1357-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MATA IF , Shi M, Agarwal P, Chung KA, et al
    SNCA Variant Associated With Parkinson Disease and Plasma {alpha}-Synuclein Level.
    Arch Neurol. 2010;67:1350-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
22. BRONSTEIN JM , Tagliati M, Alterman RL, Lozano AM, et al
    Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
23. ALCALAY RN , Caccappolo E, Mejia-Santana H, Tang MX, et al
    Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.
    Arch Neurol. 2010;67:1116-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
24. ALVAREZ-ERVITI L , Rodriguez-Oroz MC, Cooper JM, Caballero C, et al
    Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. WADIA PM , Lim SY, Lozano AM, Adams JR, et al
    Bilateral pallidal stimulation for x-linked dystonia parkinsonism.
    Arch Neurol. 2010;67:1012-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. FORSAA EB , Larsen JP, Wentzel-Larsen T, Goetz CG, et al
    A 12-year population-based study of psychosis in Parkinson disease.
    Arch Neurol. 2010;67:996-1001.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
27. KNEKT P , Kilkkinen A, Rissanen H, Marniemi J, et al
    Serum vitamin d and the risk of Parkinson disease.
    Arch Neurol. 2010;67:808-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SAVICA R , Rocca WA, Ahlskog JE
    When does Parkinson disease start?
    Arch Neurol. 2010;67:798-801.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. EVATT ML
    Beyond vitamin status: is there a role for vitamin d in Parkinson disease?
    Arch Neurol. 2010;67:795-7.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
30. DUTHEIL F , Beaune P, Tzourio C, Loriot MA, et al
    Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease.
    Arch Neurol. 2010;67:739-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. MARDER KS , Tang MX, Mejia-Santana H, Rosado L, et al
    Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
    Arch Neurol. 2010;67:731-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KASTEN M , Kertelge L, Bruggemann N, van der Vegt J, et al
    Nonmotor symptoms in genetic Parkinson disease.
    Arch Neurol. 2010;67:670-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
33. WEINTRAUB D , Koester J, Potenza MN, Siderowf AD, et al
    Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
    Arch Neurol. 2010;67:589-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. DACHSEL JC , Farrer MJ
    LRRK2 and Parkinson disease.
    Arch Neurol. 2010;67:542-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LIM SY , Hodaie M, Fallis M, Poon YY, et al
    Gamma knife thalamotomy for disabling tremor: a blinded evaluation.
    Arch Neurol. 2010;67:584-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
36. BALLANGER B , Strafella AP, van Eimeren T, Zurowski M, et al
    Serotonin 2A receptors and visual hallucinations in Parkinson disease.
    Arch Neurol. 2010;67:416-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
37. BERTONI JM , Arlette JP, Fernandez HH, Fitzer-Attas C, et al
    Increased Melanoma Risk in Parkinson Disease: A Prospective Clinicopathological Study.
    Arch Neurol. 2010;67:347-352.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
38. SHULMAN LM , Gruber-Baldini AL, Anderson KE, Fishman PS, et al
    The clinically important difference on the unified Parkinson's disease rating scale.
    Arch Neurol. 2010;67:64-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. RABINAK CA , Nirenberg MJ
    Dopamine agonist withdrawal syndrome in Parkinson disease.
    Arch Neurol. 2010;67:58-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. BRODSKY MA , Park BS, Nutt JG
    Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease.
    Arch Neurol. 2010;67:27-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: